SHERWIN STEPHEN A has filed 28 insider transactions across 2 companies since November 2022.
Most recent transaction: a gift of 1000 shares of NEUROCRINE BIOSCIENCES INC ($NBIX) on September 02, 2025.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 2, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | G | Common Stock | 1000 | $0.00 | 12,542.0000 | 103,700,000 | 7.38% | 0.00% |
| June 17, 2025 | BIOGEN INC. | $BIIB | SHERWIN STEPHEN A | Director | A | Common Stock | 2370 | $0.00 | 13,688.0000 | 169,500,000 | 20.94% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Restricted Stock Unit | 2869 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Common Stock | 2869 | $0.00 | 13,542.0000 | 103,700,000 | 26.88% | 0.00% |
| May 21, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | A | Restricted Stock Unit | 3318 | $0.00 | 3,318.0000 | 103,700,000 | 9999.99% | 0.00% |
| March 7, 2025 | BIOGEN INC. | $BIIB | SHERWIN STEPHEN A | Director | S | Common Stock | 8760 | $150.02 | 11,318.0000 | 169,500,000 | 43.63% | 0.01% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | S | Common Stock | 13831 | $116.69 | 10,673.0000 | 103,700,000 | 56.44% | 0.01% |
| Nov. 4, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | G | Common Stock | 2000 | $0.00 | 24,504.0000 | 104,300,000 | 7.55% | 0.00% |
| June 21, 2024 | BIOGEN INC. | $BIIB | SHERWIN STEPHEN A | Director | A | Common Stock | 1340 | $0.00 | 20,078.0000 | 168,700,000 | 7.15% | 0.00% |
| May 29, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Non-Qualified Stock Option | 25000 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.02% |
| May 29, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Non-Qualified Stock Option | 15000 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.01% |
| May 29, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Common Stock | 25000 | $42.76 | 51,504.0000 | 101,000,000 | 94.33% | 0.02% |
| May 29, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | S | Common Stock | 25000 | $133.46 | 26,504.0000 | 101,000,000 | 48.54% | 0.02% |
| May 29, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Common Stock | 15000 | $47.89 | 41,504.0000 | 101,000,000 | 56.60% | 0.01% |
| May 29, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | S | Common Stock | 15000 | $133.47 | 26,504.0000 | 101,000,000 | 36.14% | 0.01% |
| May 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | A | Restricted Stock Unit | 2869 | $0.00 | 2,869.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Common Stock | 4199 | $0.00 | 26,504.0000 | 101,000,000 | 18.83% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Restricted Stock Unit | 4199 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| Nov. 16, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | G | Common Stock | 2750 | $0.00 | 22,305.0000 | 98,900,000 | 10.98% | 0.00% |
| June 26, 2023 | BIOGEN INC. | $BIIB | SHERWIN STEPHEN A | Director | A | Common Stock | 960 | $0.00 | 18,738.0000 | 167,900,000 | 5.40% | 0.00% |
| May 17, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | A | Restricted Stock Unit | 4199 | $0.00 | 4,199.0000 | 98,900,000 | 9999.99% | 0.00% |
| Nov. 15, 2022 | BIOGEN INC. | $BIIB | SHERWIN STEPHEN A | Director | G | Common Stock | 695 | $0.00 | 17,778.0000 | 170,800,000 | 3.76% | 0.00% |
| Jan. 3, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Common Stock | 15000 | $12.71 | 40,055.0000 | 98,900,000 | 59.87% | 0.02% |
| Jan. 3, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | S | Common Stock | 15000 | $118.87 | 25,055.0000 | 98,900,000 | 37.45% | 0.02% |
| Jan. 3, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Common Stock | 15000 | $12.98 | 40,055.0000 | 98,900,000 | 59.87% | 0.02% |
| Jan. 3, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | S | Common Stock | 15000 | $118.85 | 25,055.0000 | 98,900,000 | 37.45% | 0.02% |
| Jan. 3, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Non-Qualified Stock Option | 15000 | $12.71 | 0.0000 | 98,900,000 | 100.00% | 0.02% |
| Jan. 3, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | SHERWIN STEPHEN A | Director | M | Non-Qualified Stock Option | 15000 | $12.98 | 0.0000 | 98,900,000 | 100.00% | 0.02% |